ARPINATI, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 2.474
EU - Europa 1.956
AS - Asia 838
AF - Africa 127
SA - Sud America 5
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.404
Nazione #
US - Stati Uniti d'America 2.461
IT - Italia 539
GB - Regno Unito 344
CN - Cina 304
SE - Svezia 295
SG - Singapore 254
DE - Germania 218
IN - India 104
RU - Federazione Russa 89
VN - Vietnam 89
IE - Irlanda 85
UA - Ucraina 73
AT - Austria 57
FI - Finlandia 56
TG - Togo 50
FR - Francia 43
BG - Bulgaria 38
JO - Giordania 36
CI - Costa d'Avorio 35
NL - Olanda 28
EE - Estonia 23
ZA - Sudafrica 21
BE - Belgio 18
CH - Svizzera 18
NG - Nigeria 14
CA - Canada 13
JP - Giappone 10
ID - Indonesia 8
IR - Iran 8
TR - Turchia 6
SC - Seychelles 5
HR - Croazia 4
LT - Lituania 4
PK - Pakistan 4
AU - Australia 3
CL - Cile 3
CZ - Repubblica Ceca 3
ES - Italia 3
KR - Corea 3
NO - Norvegia 3
BD - Bangladesh 2
DK - Danimarca 2
HU - Ungheria 2
KE - Kenya 2
PL - Polonia 2
RS - Serbia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BR - Brasile 1
EC - Ecuador 1
GR - Grecia 1
HK - Hong Kong 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MK - Macedonia 1
MY - Malesia 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 5.404
Città #
Chandler 319
Southend 301
Fairfield 266
Singapore 224
Ashburn 169
Bologna 161
Woodbridge 125
Houston 117
Ann Arbor 115
Wilmington 113
Seattle 112
Princeton 87
Dublin 85
Cambridge 79
Santa Clara 75
New York 61
Boardman 59
Dong Ket 55
Helsinki 55
Lomé 50
Jacksonville 46
Sofia 38
Vienna 38
Amman 36
Nanjing 36
Abidjan 35
Bremen 34
Milan 34
Westminster 32
Florence 27
Beijing 24
Padova 24
Turin 24
Berlin 23
San Diego 20
Brussels 18
Falls Church 17
Rome 17
Redmond 16
Saint Petersburg 16
Abeokuta 14
Bern 14
Los Angeles 13
Redwood City 12
Falkenstein 11
Hyderabad 10
Pune 10
Tokyo 10
Toronto 10
Changsha 9
Hangzhou 9
Jinan 9
Medford 9
Mülheim 9
Shenyang 9
Des Moines 8
Hebei 8
Jakarta 8
Nuremberg 8
Washington 8
London 7
Nanchang 7
Shanghai 7
Tianjin 7
Verona 7
Zhengzhou 7
Guangzhou 6
Haikou 6
Phoenix 6
Yubileyny 6
Amsterdam 5
Bari 5
Jiaxing 5
Kunming 5
Modena 5
Mountain View 5
Ravenna 5
Reggio Emilia 5
San Francisco 5
Taiyuan 5
Taizhou 5
York 5
Andover 4
Boydton 4
Forlì 4
Genoa 4
Mahé 4
Meda 4
Ningbo 4
Olalla 4
Osimo 4
Sacramento 4
Shenzhen 4
Assisi 3
Buffalo 3
Calderara di Reno 3
Dehradun 3
Frankfurt am Main 3
Fremont 3
Fuzhou 3
Totale 3.572
Nome #
Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation. 259
Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation 196
Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. 162
Clinical utility of measuring Epstein-Barr virus-specific cell-mediated immunity after HSCT in addition to virological monitoring: results from a prospective study. 162
Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors. 160
Successful treatment of severe hemorrhagic cystitis with selective vesical artery embolization. 155
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia 151
Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade). 149
Developing a new grading system of ocular surface disease after allogeneic hematopoietic stem cell transplantation (HSCT). 141
Efficacy of standardized and quality-controlled cord blood serum eye drop therapy in the healing of severe corneal epithelial damage in dry eye 133
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition 130
In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study. 129
Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients. 126
Follicle features in adolescent and young adult women with Hodgkin's disease prior to chemotherapy: a preliminary report. 126
Eyelid metrics assessment in patients with chronic ocular graft versus-host disease 126
Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: implication for daily clinical practice 124
Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes. 124
Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis 119
Meibomian Gland Dropout in Hematological Patients Before Hematopoietic Stem Cell Transplantation 118
Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target? 117
In vitro growth and differentiation of human dental pulp derived multipotent mesenchymal stem cells. 115
Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function 115
Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B 112
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 112
Increased donor CD86+CD14+ cells in the bone marrow and peripheral blood of patients with chronic graft-versus-host disease. 111
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 104
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells 102
Kinetics of Th1/Th2 cytokines and lymphocyte subsets to predict chronic GVHD after allo-SCT: results of a prospective study. 102
Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients 101
Peripheral blood cellular profile at pre-lymphodepletion is associated with {CD}19-targeted {CAR}-T cell-associated neurotoxicity 99
Validation of the New European LeukemiaNet (ELN) Recommendations for Bcr-Abl Kinase Domain Mutation Analysis In Chronic Myeloid Leukemia: An Analysis of the GIMEMA CML Working Party Studies 92
null 86
Meibomian Gland Dropout in Hematological Patients Prior to Hematopoietic Stem Cell Transplantation 85
Molecular monitoring of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukaemia 85
null 83
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant 81
Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study 76
Longitudinal tear protein changes correlate with ocular chronic gvhd development in allogeneic hematopoietic stem cell transplant patients 76
Score predittivo di dry eye in corso di CGVHD dopo trapianto allogenico con cellule staminali emopoietiche 75
null 75
Transfusion-related Listeria monocytogenes infection in a patient with acute myeloid leukaemia 73
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 65
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases 63
Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas 63
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment 60
Dry Eye Disease Is Already Present in Hematological Patients before Hematopoietic Stem Cell Transplantation 60
Transient Elastography Anticipates the Diagnosis of VOD/SOS after Adult Allogeneic Stem Cell Transplant: Results from a Prospective Study 55
Incidence, Risk Factors and Complications of Ocular Graft-Versus-Host Disease Following Hematopoietic Stem Cell Transplantation 55
Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement 52
A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation 49
Longitudinal Changes of Ocular Surface Microbiome in Patients Undergoing Hemopoietic Stem Cell Transplant (HSCT) 49
Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study 43
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 36
Epigenetic age acceleration in hematopoietic stem cell transplantation 21
Sequence and expression analysis of the β-2-microglobulin gene in dialysis patients 15
Totale 5.553
Categoria #
all - tutte 16.590
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.590


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020277 0 0 0 0 0 0 0 0 121 64 47 45
2020/2021477 99 34 13 15 21 29 8 33 43 41 30 111
2021/20221.003 59 24 55 118 67 45 32 75 59 115 233 121
2022/20231.371 144 179 76 177 108 99 38 74 233 24 143 76
2023/2024494 38 63 35 49 43 136 20 23 16 21 34 16
2024/20251.000 65 203 123 127 160 93 127 79 23 0 0 0
Totale 5.553